Atorvastatin Related Compound C (20 mg) (Difluoro impurity,or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acidcalcium salt)
-
Atorvastatin Related Compound C (20 mg) (Difluoro impurity,or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acidcalcium salt)
structure -
-
CAS No:
693793-53-2
-
Formula:
C66H68CaF2N4O10
-
Chemical Name:
Atorvastatin Related Compound C (20 mg) (Difluoro impurity,or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acidcalcium salt)
-
Synonyms:
Atorvastatin Related Compound C (20 mg) (Difluoro impurity,or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acidcalcium salt);Atorvastatin Related CoMpound C;Difluoro iMpurity, or (3R,5R)-7-[3-(phenylcarbaMoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calciuM salt;Difluoro Atorvastatin SodiuM Salt;Atorvastatin EP IMpurity C;Difluoro Atorvastatin CalciuM Salt;(betaR,deltaR)-2,3-Bis(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1);Atorvastatin impurity C
- Categories:
-
CAS No:
Atorvastatin Related Compound C (20 mg) (Difluoro impurity,or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acidcalcium salt) Basic Attributes
1155.3417264
576.243591
2933997500
Computed Properties
Molecular Weight:1191.3
Hydrogen Bond Donor Count:6
Hydrogen Bond Acceptor Count:14
Rotatable Bond Count:22
Exact Mass:1190.4340978
Monoisotopic Mass:1190.4340978
Topological Polar Surface Area:229
Heavy Atom Count:85
Complexity:850
Defined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:3
Compound Is Canonicalized:Yes
Recommended Suppliers of Atorvastatin Related Compound C (20 mg) (Difluoro impurity,or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acidcalcium salt)
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives
Latest News on Atorvastatin Related Compound C (20 mg) (Difluoro impurity,or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acidcalcium salt)
- The world's first uniform international safety standard for plastics and rubber
- The nation's first group standard for meltblown cloth for masks is released
- Several compulsory national standards have been issued
- Japan has seized the right to formulate international standards
- Henan Efforts to Improve the Standardized Management Level of Food Production
Learn More Other Chemicals
-
Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)
72901-16-7
-
Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester)
35888-94-9
-
Efavirenz Related Compound C (20 mg) (6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline)
391860-73-4
-
Atorvastatin Related Compound A (20 mg) (Desfluoro impurity,or (3R,5R)-7-[3-(phenylcarbamoyl)-2-isopropyl-4,5-diphenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acidcalcium salt) Formula
433289-83-9
-
Atorvastatin Related Compound D (20 mg) (Epoxide impurity,or 3-(4-Fluorobenzoyl)-2-isobutyryl-3-phenyl-oxirane-2-carboxylic acid phenylamide) Formula
148146-51-4
-
Fluocinolone Formula
807-38-5
-
2-Propenoic acid, 2-methyl-, methyl ester, polymer with butyl 2-propenoate, 2-ethylhexyl 2-propenoate and 2-propenoic acid Structure
42398-14-1
-
(3S,7R)-N-[(2-fluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide Structure
1863916-87-3
-
What is 1,1-Cyclopropanedicarboxylic acid, 1,1-dimethyl ester
6914-71-2
-
What is (6R,7R)-7-[[2-amino-2-(cyclohexen-1-yl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
37051-00-6
Request for Quotation